Erste Asset Management GmbH boosted its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 251.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 59,369 shares of the conglomerate’s stock after acquiring an additional 42,456 shares during the quarter. Erste Asset Management GmbH’s holdings in Danaher were worth $13,702,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently bought and sold shares of the business. O Shaughnessy Asset Management LLC boosted its stake in Danaher by 38.3% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 110,725 shares of the conglomerate’s stock worth $25,347,000 after buying an additional 30,692 shares in the last quarter. Manchester Capital Management LLC boosted its stake in Danaher by 2.0% during the fourth quarter. Manchester Capital Management LLC now owns 3,319 shares of the conglomerate’s stock worth $760,000 after buying an additional 64 shares in the last quarter. Hilton Head Capital Partners LLC acquired a new stake in Danaher during the fourth quarter worth $27,000. HFR Wealth Management LLC boosted its stake in Danaher by 0.5% during the fourth quarter. HFR Wealth Management LLC now owns 42,696 shares of the conglomerate’s stock worth $9,774,000 after buying an additional 192 shares in the last quarter. Finally, CNB Bank boosted its stake in Danaher by 4.4% during the fourth quarter. CNB Bank now owns 4,875 shares of the conglomerate’s stock worth $1,116,000 after buying an additional 204 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Stock Down 0.5%
Shares of NYSE DHR opened at $183.47 on Tuesday. The stock has a market cap of $129.85 billion, a PE ratio of 35.49, a PEG ratio of 2.46 and a beta of 0.81. The business has a fifty day moving average of $181.19 and a two-hundred day moving average of $205.80. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.
Analysts Set New Price Targets
DHR has been the topic of a number of recent research reports. Robert W. Baird decreased their price target on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. Wells Fargo & Company decreased their price target on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Royal Bank Of Canada initiated coverage on shares of Danaher in a research note on Thursday, May 14th. They set an “outperform” rating and a $200.00 price target on the stock. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Finally, Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $235.14.
Get Our Latest Research Report on DHR
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
